INDUSTRY NEWS ThermoGenesis Announces Major Strategic Development with Completion of New Distribution Agreement with GE Healthcare Under the revised distribution contract, which runs through July, 2012, GE Healthcare will continue to distribute the AXP product line, excluding certain countries in Latin and South America, Asia, CIS and Eastern Europe. [ThermoGenesis Corp. Press Release] Cord Blood America Finalizes Cord Blood Stem Cell Processing and Storage Agreement with BioCells, a Major South American Company Cord Blood America, Inc. stated recently that it has finalized an agreement to process and store cord blood specimens for BioCells, Inc., headquartered in Argentina, and its affiliates in Peru, Colombia, Bolivia, Panama and Puerto Rico. [Cord Blood America, Inc. Press Release] Elbit Imaging Announces Data Monitoring Committee Recommends Continuation of Phase III Study of StemEx®, a Cord Blood Stem Cell Product, for Leukemia and Lymphoma Elbit Imaging Ltd. announces that its associated company, Gamida Cell Ltd. through the Gamida-Teva Joint Venture (JV), announced that the Data Monitoring Committee has independently reviewed preliminary data from the pivotal registration, Phase III clinical trial of StemEx and has recommended that the JV continue to enroll patients in this study. [Elbit Imaging Ltd. Press Release] Biologics, Inc. Selected to Provide Pharmacy Management Services in National Marrow Donor Program Clinical Trial Biologics, Inc. announces that its Oncology Clinical Trial Services division has been selected by the National Marrow Donor Program®, a nonprofit organization that facilitates unrelated hematopoietic cell transplants. [Biologics, Inc. Press Release] Athersys Receives United States Patent Covering Adult Stem Cell Composition & Production Athersys, Inc. announced that it has been granted U.S. patent 7,659,118 that covers non-embryonic multipotent stem cells, their isolation and expansion, and related pharmaceutical compositions. [Athersys, Inc. Press Release] Cerus Corporation Reports Positive Outcome of Phase 1 Clinical Trial of INTERCEPT Red Blood Cells Cerus Corporation announced that its Phase I trial of red blood cells treated with the INTERCEPT Blood System met its primary endpoint, with preliminary analysis demonstrating that greater than 75 percent of treated cells continued to circulate 24 hours following transfusion. [Cerus Corporation Press Release] Cerus to Collaborate with French National Transfusion Service on INTERCEPT Red Blood Cell Development Cerus Corporation announced that it has entered into a collaborative agreement with France’s national transfusion service, the Etablissement Francais du Sang, for the development of the company’s INTERCEPT Blood System for red blood cells. [Cerus Corporation Press Release] Debate in United States Over Blood from Newborn Safety Tests A critical safety net for babies, that heel prick of blood taken from every newborn in the U.S., is facing an ethics attack. [Associated Press]
|
POLICY NEWS New 10-Year United Kingdom Blood Stem Cell Strategy to be Created Gillian Merron, Public Health Minister, has asked the National Health Service Blood and Transplant to lead a team of experts in creating a new 10-year strategy for the provision of blood stem cells, including those from cord blood to fight leukaemias and other blood disorders. [National Health Service Blood and Transplant Press Release] Senate Rejects Stem Cell Legislation By a vote of 21 to 12, the South Dakota Senate shot down a bill that could have repealed South Dakota’s ban on embryonic stem cell treatments. [South Dakota Senate, United States] Parsing National Institutes of Health’s 2011 Budget: Is Big Science Up, Small Science Down? Is National Institutes of Health Director Francis Collins planning to steer his ocean liner of an institute toward “big biology” at the expense of single-investigator grants? [National Institutes of Health, United States] Medvedev Talks Science in Moscow Russian science has been getting some bad press recently, what with a recent report on its declining productivity in scientific papers and a letter from expatriate scientists to the Russian president and prime minister warning of the parlous state of basic research. [Russian Academy of Sciences, Russia] Impersonation of MHRA Staff [Medicines and Healthcare Products Regulatory Agency, United Kingdom] Waivers for Conflicts of Interest for the February 22, 2010 Vaccines and Related Biological Products Advisory Committee Meeting [Center for Biologics Evaluation and Research, United States] Recovery Act Limited Competition: Program to Enhance National Institutes of Health-Supported Global Health Research Involving Human Subjects (S07) (RFA-OD-10-006) [National Institutes of Health, United States] Institutional Clinical and Translational Science Award (U54) (RFA-RM-10-001) [National Institutes of Health, United States] IACUC 101 Workshop and PRIM&R 2010 IACUC Conference: March 21-23, 2010 in Baltimore, MD (NOT-OD-10-059) [National Institutes of Health, United States] Delays in Grant Application Submission Due to Blizzard (NOT-OD-10-060) [National Institutes of Health, United States] Notice of Intent to Establish a New National Institutes of Health Common Fund Program: Library of Integrated Network-Based Cellular Signatures (LINCS) (NOT-RM-10-002) [National Institutes of Health, United States] Investigator Initiated Multi-Site Clinical Trials (Collaborative R01) (PAR-10-096) [National Heart, Lung, and Blood Institute, United States]
|
EVENTS 2010 Blood and Marrow Transplant (BMT) Tandem Meetings February 24-28, 2010 Orlando, United States American Association of Blood Banks (AABB) Cord Blood Licensure Workshop March 8-10, 2010 Rockville, United States 36th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT) March 21-24, 2010 Vienna, Austria 12th Biennial Canadian Blood and Marrow Transplant Group (CBMTG) Conference April 7-10, 2010 Vancouver, Canada American Association for Cancer Research (AACR) 101st Annual Meeting 2010 April 17-21, 2010 Washington, DC, United States British Society for Haematology 50th Annual Scientific Meeting April 19-21, 2010 Edinburgh, Scotland XXIII International Symposium on Technological Innovations in Laboratory Hematology May 10-12, 2010 Brighton, United Kingdom 16th Annual International Society for Cellular Therapy (ISCT) Meeting May 23-26, 2010 Philadelphia, United States 8th Annual International Umbilical Cord Blood Transplantation Symposium June 3-5, 2010 San Francisco, United States International Society for Stem Cell Research (ISSCR) 8th Annual Meeting June 16-19, 2010 San Francisco, United States Select Bioscience’s World Biobanking Summit August 24-25, 2010 Edinburgh, Scotland International Society for Hematology and Stem Cells (ISEH) 2010 Meeting September 15-18, 2010 Melbourne, Australia
JOB OPPORTUNITIES Business Development Europe – Cell Therapy Products (PALL Corporation) Recruit Top Talent Reach more than 11,000 potential candidates by posting your organization’s career opportunities with Cord Blood News. Visit here to post your career opportunities.
Have we missed an important article or publication in Cord Blood News? Click here to submit!
|
|
|